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Abstract
According to Martin and Larson (2003), healthcare professionals involved with 
handling antineoplastic drugs may be exposed inadvertently to these agents, placing them 
at potential risk for acute and long-term adverse effects. For example, cyclophosphamide 
one of the most frequently used antineoplastic agents in clinical treatment facilities, is a 
known human carcinogen (Larson, Khazaeli, & Dillon, 2003). While the health risks 
associated with cytotoxic use have been well established, there is little information 
available about how people perceive these risks, particularly among those most affected 
by it-chemotherapy nurses. Therefore, the purpose of this Evidence Based Practice (EBP) 
project was to develop a nurse practitioner knowledgebase regarding the impact of risk 
perception on the cytotoxic agent safety behaviors of oncology nurses. The research 
questions asked: (a) what is the level of healthcare knowledge regarding the role of the 
healthcare provider in facilitating risk surveillance of occupational exposure to 
antineoplastic agents? (b) according to the literature, how can healthcare providers 
contribute to cost-effective, high-quality care by facilitating risk surveillance of 
occupational hazards? and (c) according to the literature, how can healthcare providers
contribute to cost-effective, high-quality care by facilitating risk surveillance of exposure 
to antineoplastic agents? A Boolean computer search of nursing and medical literature 
for theory-based, data-based, randomized controlled trials for citations utilizing 
CINAHL, MEDLINE, and the Cochrane Library was conducted for this systematic 
review.
Becker’s Health Belief Model (1974) served as the theoretical foundation for this 
clinical project and guided the systematic review through data collection of the healthcare 
literature. Literature reviewed totaled 8 manuscripts, which represented reviews of 
another 122 references. Studies o f healthcare workers have shown that occupational 
exposure to antineoplastic agents has caused acute adverse effects such as nausea, 
headache and dizziness (Valanis, Vollmer, Labuhn, & Glass, 1997). Exposure risk and its 
relationship to healthcare professionals’ compliance to established protocols for the safe 
handling and administration of chemotherapy agents continues to be a concern for health 
care institutions (Ritchie, McAdams, & Fritz, 2000). The literature reviewed for this 
study recommends compliance with established safety guidelines to ensure adequate 
protection to those involved in the handling, administration, and care of patients receiving 
antineoplastic agents. Yet despite the adoption of these guidelines in healthcare 
institutions, the current literature also suggests that many workers do not follow the 
standards established by their employers and current OSHA guidelines, putting 
themselves at risk for exposure to potential mutagenicity, alterations in fertility and long­
term effects from chemotherapy agents (Valanis, Vollmer, Labuhn, & Glass, 1997).
Using an Evidence Based Medicine (EBM) approach, based on that of Sackett, 
Straus, Richardson, Rosenberg, and Haynes (2000), a knowledgebase was developed
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according to methods described by Davidson (2003) in which key findings from the 
systematic review of randomized control trials, data-based and theory-based literature 
were compared with current practice guidelines, resulting in a number of safe practice 
recommendations. These recommendations emphasize that safe levels of exposure to 
antineoplastic agents have not been determined therefore; it is essential to minimize 
exposure.
The need for fiirther attention to risk surveillance of occupational exposure to 
antineoplastics in advanced practice nursing literature is critical. Evidence-based practice 
modalities that will utilize current guidelines in the risk surveillance of occupational 
exposure to antineoplastic agents are essential for nurse practitioner application in 
oncology settings. Implications for nursing theory, nursing research, advanced nursing 
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CHAPTER I 
Dimensions of the Problem
Occupational exposure to harmtiil agents has been identified as a problem of 
increasing health concern (Martin & Larson, 2003). Agencies such as the Oncology 
Nursing Society, the Occupational Safety and Health Administration, and the American 
Society of Health-Systems Pharmacists have developed guidelines for the safe handling 
of hazardous drugs because of the potential dangers they present. According to Martin 
and Larson, compliance with established safety guidelines is increasing as compared to 
previous chemotherapy-handling studies. However, many health professionals continue 
to disregard these guidelines in their everyday practice.
The administration of chemotherapeutic agents is an integral part of nurses’ role 
in the provision of care. Cytostatic drugs possess toxic properties and may cause 
mutagenic, carcinogenic and teratogenic effects. Therefore, nurses handling these drugs 
in the course of their profession may face serious health risks. The occupational exposure 
risk of cytotoxic agents was first documented in healthcare personnel by Falck et al. 
(1979), who reported an elevated frequency of mutagenesis in spot urines after 
continuous low-level exposure within a group of oncology nurses. Proper handling of 
these drugs combined with the use of personal protective equipment can drastically 
reduce this threat.
Problem Statement
While the health risks associated with cytotoxic use have been well established, 
there is little information available about how people perceive these risks, particularly 
among those most affected by it-chemotherapy nurses. Chemotherapy is a treatment
1
method of choice for many cancers. The preparation and administration of 
chemotherapeutic agents is often a primary responsibility of the oncology nurse. 
According to Martin and Larson (2003), healthcare professionals involved with handling 
antineoplastic drugs may be exposed inadvertently to these agents, placing them at 
potential risk for acute and long-term adverse effects. For example, cyclophosphamide is 
one of the most fi-equently used antineoplastic agents in clinical treatment facilities, and 
is a known human carcinogen (Larson, Khazaeli, & Dillon, 2003).
Generally, the occupational activities that pose the greatest risk of exposure are the 
preparation and administration of antineoplastic agents, cleaning of chemotherapy spills, 
and handling of patient excreta (Martin & Larson, 2003). Agencies such as the Oncology 
Nursing Society have developed guidelines for the safe handling of hazardous drugs 
because of the potential dangers they present. These guidelines are recommendations that 
are intended to improve the routine involved with the pr^aration and administration of 
chemotherapy. Thus, the problem statement that was generated for the scope of this 
investigation concerns the role of the healthcare provider in facilitating risk surveillance 
of occupational exposure to antineoplastic agents.
Statement o f Purpose
Exposure risk and its relationship to healthcare professionals’ compliance to 
established protocols for the safe handling and administration of chemotherapy agents 
continues to be a concern for healthcare institutions (Ritchie, McAdams, & Fritz, 2000). 
Studies of healthcare workers have shown that chemotherapy drugs have caused acute 
adverse effects such as nausea, headache and dizziness (Valanis, Vollmer, Labuhn, & 
Glass, 1997). Other potential long-term adverse reactions documented in the literature
related to occupational exposure to antineoplastics include chromosomal aberrations and 
adverse reproductive outcomes. Currently, there does not exist sufficient research to 
explain why some healthcare workers do not follow recommended precautions (Ritchie et 
al, 2000). Future nursing research should focus on assessing and identifying ways to 
increase awareness and encourage compliance.
Significance o f the S tu ^
The current level of healthcare knowledge regarding the role of the healthcare 
provider in facilitating risk surveillance of occupational exposure to antineoplastic agents 
is limited. A computer search utilizing CINAHL, MEDLINE, and Cochrane Library, 




Search Terms Number of Citations Database
nurs* and risk surveillance 1 CINAHL
2 MEDLINE
31 COCHRANE
nurs* and occupational exposure 1002 CINAHL
1202 MEDLINE
35 COCHRANE
nurs* and chemotherapy agents 29 CINAHL
30 MEDLINE
nurs* and antineoplastic agents
risk surveillance and occupational
exposure
nurse practitioner and Becker
risk surveillance and Becker






























Note, CINAHL ~ Cumulative Index to Nursing and Allied Health Literature, MEDLINE 
= Medical Literature Online, COCHRANE = Cochrane Library (Cochrane Database of 
Systematic Review, Cochrane Database of Abstracts of Reviews of Evidence, and 
Cochrane Clinical Trials Register).
Clinical significance regarding the role of the healthcare provider in facilitating 
risk surveillance of occupational exposure to antineoplastic agents is focused on the need 
for cost-effective, high-quality care. In spite of the medical benefits resulting from the
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use of these drugs, they may be potentially harmful to workers handling them. Adverse 
health effects from both acute and chronic exposures have been demonstrated in 
healthcare personnel. In 1979, the British journal. Lancet, published a report suggesting 
that healthcare personnel handling antineoplastic agents may be at risk. This study by 
Falck et al. (1979) showed mutagenic activity in the urine of nurses working in an 
oncology unit, and proposed that the cause was related to exposure to antineoplastic 
agents. This was the first look at the carcinogenic risk of antineoplastics from an 
occupational standpoint. The clinical significance regarding the occupational exposure 
risks associated with antineoplastic use is tremendous.
Theoretical Foundation 
The Health Belief Model (HBM) and its extended form, the Protection Motivation 
Theory (PMT) state that the adoption of a behavior appropriate to the prevention or 
control of some disease depends on the individual’s perception of a threat to personal 
health and a conviction that the recommended action will reduce this threat (Floyd, 
Prentice-Dunn, & Rogers, 2000). The Protection Motivation Theory has been used in 
many studies that attempt to explain why behavioral choices are made, thus is an 
appropriate theoretical framework for this study. The perception of a health threat is 
determined by the strength of two underlying beliefs: personal susceptibility to a given 
disease and the potential severity of its impact on the individual’s life. These perceptions 
can be awakened or strengthened through a striking event. The perceived efficacy of the 
recommended preventive action depends on a personal assessment of the perceived 
benefits of the proposed behavior and real or perceived barriers to initiation or 
continuation of the suggested behavior. The Protection Motivation Theory assumes that
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anticipation of a negative health outcome and the desire to avoid this outcome or reduce 
its impact creates motivation for self-protection (Rogers, 1983). And that intent to change 
behavior is generated only when the benefits outweigh the costs associated with making 
the change.
According to the PMT, a maladaptive response like not using protective 
equipment is facilitated by certain rewards. For example, nurses’ can quickly prepare and 
administer the chemo without having to adorn all sorts of protective equipment. This 
translates into less time patients have to wait. The maladaptive response is also inhibited 
by the perceived severity of exposure risk and nurses’ perceived vulnerability to it. In the 
PMT, anxiety has no direct relation with behavioral intention or behavior, but is mediated 
by perceived vulnerability, which is seen as a cognitive representation of anxiety (Floyd, 
Prentice-Dunn, & Rogers, 2000). Adaptive responses, such using personal protective 
equipment is, according to the model, facilitated by response efficacy and self-efficacy.
In this context, response efficacy refers to the belief that using protective equipment 
reduces the risks of exposure. Self-efficacy refers to the perceived ability to perform 
these behaviors consistently. While it cannot predict the amount of behavior change that 
will occur following an intervention. Protection Motivation Theory can predict whether 
some groups more than others will benefit from interventions based on the theory 
(Rogers, 1983). The Protection Motivation Theory has been used in many studies that 
attempt to explain why behavioral choices are made, thus is an appropriate theoretical 
framework for this study.
Definition o f Terms 
For the purposes of this study, the following terms are defined:
Risk SurvdUance
Theoretical Life is a risky business and deciding which risks are worth taking 
and which should be avoided has important implications for an individual’s lifestyle. The 
benefits gained fi*om taking a risk need to be weighed against the possible disadvantages. 
Different people have a different level of preference for taking risks. Some people go 
bungee-jumping in their free time while others prefer to read. Demographic variables 
have a large effect on risk propensity. For example, males have a higher risk inclination 
than females; older people have a lower risk inclination than younger people; different 
cultures endorse different risk-taking values; and person with more depmdents will tend 
to take fewer risks (Lipshitz, Klein, Orasanu, & Salas, 2001).
Risk perception also depends on experience. An inexperienced decision-maker 
will perceive lower risk, and as a result, might often take greater risks than desirable. 
Also, because his or her decision is based on only a small sample of past decisions and 
outcomes, it is likely that an additional piece of information might cause him or her to 
change the decision (Lipshitz et al., 2001). A moderately experienced decision-maker 
sees all the risks involved and is not as likely to be affected by additional information, 
since he or she has more to experience to base the decision on. Just like the moderately 
experienced decision-maker, the expert knows about all the risks; however, because of 
his or her past experience, the expert might be overconfident and again perceive the risks 
as lower than they actually are, potentially leading to overconfidence. Lastly, risk 
perception is affected by perceived responsibility for the outcome: people will regard as 
more risky situations that they have frill responsibility. Therefore, many people try to
8
limit their personal responsibility for risky outcomes by discussing the decision with 
their superiors or their team.
Operational Research shows that people tend to overestimate the probability of 
unfamiliar, catastrophic and well-publicized events and to underestimate the probability 
of unspectacular or familiar events (Lipshitz et al., 2001). Misperception of risk can lead 
to unreasonable concern about a hazard. Given a chance, people would rather not have to 
confront the risks inherent in life’s activities. Psychological research shows that 
whenever possible, people attempt to reduce the anxiety generated in the face of 
uncertainty by denying that uncertainties, thus making the risk seem either so small that it 
can safely be ignored or so large that it clearly should be avoided. They are 
uncomfortable when given statements of probability rather than fact; they want to know 
exactly what will happen. The general public’s perceptions of risk are often highly 
inaccurate, but by underestimating common risks while exaggerating exotic ones, we 
may end up protecting ourselves against the unlikely perils while failing to take 
precautions against those that are far more dangerous.
Occupational Ejqfosure
Theoretical Occupational exposure is the reasonably anticipated skin, eye, 
mucous membrane, or parenteral contact with blood or other potentially hazardous 
materials that may result from the performance of an employee's duties. Occupational 
exposure to hazardous drugs and the resulting potential health risk to healthcare workers 
first became a recognized safety concern in the 1970s. Traditional assumptions about safe 
drug handling were challenged by a study published in a recent edition of the American 
Journal of Health-System Pharmacy. This study confirmed that, despite existing
9
protective measures, there persists widespread surface contamination with antineoplastic 
drugs in the workplace and employee e?q)Osure to carcinogenic or mutagenic particulates 
and vapors.
The inadvertent introduction of hazardous drugs into an environment can occur in 
various ways. Drug containers may become damaged in the shipping process. A broken, 
cracked, or otherwise damaged container may result in leakage of the hazardous materials 
onto other containers. If not properly inspected upon receipt, the shipping container can 
be opened in the receiving area, exposing receiving personnel to the hazardous agent. In 
addition, contamination of the surrounding drug storage areas may occur. The 
manipulation required to prepare hazardous drugs for administration may also lead to 
environmental contamination. Leaks, spills, and the creation of aerosols of liquid drugs 
can occur during dose preparation. The process of priming IV tubing may lead to 
inadvertent environmental contamination if the priming process is not performed 
appropriately. In addition, during drug administration, tubing and injection port 
connections that are not properly secured may lead to leakage of the prepared agent. 
Inappropriate disposal of hazardous drugs, either from the clean-up of spills or leaks, or 
from waste created during drug preparation and administration, can also lead to 
environmental contamination.
Operational Mutagenic changes in the urine and evidence of chromosome 
damage in healthcare personnel who have prepared or administered antineoplastic drugs 
led to the conclusion that handling such drugs poses a genuine health risk to the 
individuals involved. Because these measures were indirect, and a direct cause-and-effect 
relationship could not be determined, more direct methods of determining exposure have
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been developed. These methods include urinalysis to determine the presence of 
metabolites of dangerous drugs handled by healthcare workers, and environmental air and 
surfece sampling techniques 
Antineoplastic Agents
Theoretical These agents are chemotherapy drugs that modify the growth and 
reproduction of cancer cells through alteration of the genetic material thereby destroying 
them. Despite the medical benefits of these drugs, they may be potentially harmful to 
workers handling them. Many chemotherapeutic drugs are known human carcinogens, for 
which there is no safe level o f exposure. Falck et al. (1979) were the first to note 
evidence of mutagenicity in the urine of nurses who handled cytotoxic drugs. Researchers 
have also studied pharmacy personnel who handled antineoplastic drugs. The researchers 
showed increasingly mutagenic urine over the period of exposure; when they stopped 
handling the drugs, activity fell within 2 days to the level of unexposed controls (Nguyen, 
Theiss, & Matney, 1982). The researchers also found mutagenicity in workers using 
horizontal laminar flow hoods that decreased to control levels with the use of vertical 
flow containment hoods.
Operational Generally, the occupational activities that pose the greatest risk of 
exposure are the preparation and administration of antineoplastic agents, cleaning of 
chemotherapy spills, and handling of patient excreta (Martin & Larson, 2003). The 
Occupational Safety & Health Administration has created guidelines to control 
occupational exposure to hazardous drugs like the cytotoxic agents used in cancer 
treatment facilities. Safe levels of exposure have not been determined therefore; it is 
essential to minimize exposure to these agents.
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The guidelines recommends that chemotherapy preparation be performed in a 
restricted, preferably, centralized area (OSHA, 1999). Signs restricting the access of 
unauthorized personnel are to be prominently displayed. Eating, drinking, smoking, 
chewing gum, applying cosmetics, and storing food in the preparation area should be 
prohibited. OSHA also recommends that procedures for spills and emergencies, such as 
skin or eye contact be posted in this area. The use of class II or HI Biological Safety 
Cabinets should minimize exposure during preparation. Decontamination of the hood 
should be performed routinely and serviced by a qualified technician at least every six 
months.
Research indicates that the thickness of the gloves used in handling 
antineoplastics is more important than the type of material, since all materials tested have 
been found to be permeable to some agents (Singleton & Connor, 1999). Because all 
gloves are permeable to some extent and their permeability increases with time, they 
should be changed regularly (hourly) or immediately if they are tom, punctured, or 
contaminated with a spill (OSHA, 1999).
A protective disposable gown made of lint-free, low-permeability fabric with a 
closed front, long sleeves, and elastic or knit closed cuffs should be worn (OSHA, 1999). 
The cuffs should be tucked under the gloves. Eye and face protective equipment should 
be worn whenever splashes, sprays, or aerosols of chemo may be generated. All gowns, 
gloves, and disposable materials used in preparation should be disposed of according to 
the hospital's hazardous dmg waste procedures and as described under this review's 
section on waste disposal. Goggles, face shields and respirators may be cleaned with mild 
detergent and water for reuse.
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Findings from e^dsting research indicate that compliance with established 
safety guidelines offers adequate protection to those healthcare workers involved in the 
handling, administration, and care of patients receiving chemotherapy agents (Ritchie, 
McAdams, & Fritz, 2000). Despite the adoption of these guidelines in healthcare 
institutions, reports in the current literature suggest that some workers do not follow the 
standards established by their employers and current OSHA guidelines, putting 
themselves at risk for exposure to potential mutagenicity, alterations in fertility and long­
term effects from chemotherapy agents (Valanis, Vollmer, Labuhn, & Glass, 1997), 
Valanis, McNeil, and Driscoll (1991) found like results among staff members’ adherence 
to fecility protocol regarding the handling of cytotoxic agents. Ben-Ami, Shaham, Rabin, 
and Ribak (2001) showed that notwithstanding the rules and regulations pertaining to 
cytotoxic drugs, nurses in the study did not comply to them fully. The safety behavior of 
exposed nurses and the relative usage of safety equipment were related to their appraisal 
of their susceptibility to becoming ill.
Nurses have given a number of reasons for not wearing protective equipment 
when handling cytotoxic drugs (Valanis, McNeil, & Driscoll, 1991). Barriers to using the 
protective equipment include that it is inconvenient to wear, time-consuming and 
awkward to apply, and not readily available (Mahon, Casperson, Yackzan, Goodner, 
Hasse, Hawkins et al., 1994). Other barriers include a lack of awareness of the health 
risks of handling cytotoxic drugs, disbelief that a danger actually exists despite being 
informed, and a concern that wearing the protective equipment may upset the patient 
(Mahon et al., 1994).
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Research Questions
For the purposes of this study, the following research questions were generated:
1. What is the level of healthcare knowledge regarding the role of the healthcare 
provider in facilitating risk surveillance of occupational exposure to antineoplastic 
agents?
2. According to the literature, how can healthcare providers contribute to cost- 
effective, high-quality care by facilitating risk surveillance of occupational 
hazards?
3. According to the literature, how can healthcare providers contribute to cost- 
effective, high-quality care by facilitating risk surveillance of exposure to 
antineoplastic agents?
Delimitations
Literature was delimited, for the purpose of this integrative literature review, to the 
following:
1. Literature that pertains to the role of the healthcare provider in facilitating risk 
surveillance of occupational exposure to antineoplastic agents.
2. Literature that is available in the English language or translated into English 
abstracts.
3. Literature available through CINAHL, MEDLINE, and Cochrane Libraries.
4. Literature that is available through the Mississippi University for Women Library 
and Interlibrary loan program.
14
LimiUUions
For the purpose of this investigation a particular limitation identified is that the 
information obtained cannot be generalized beyond the scope of the research reviewed. 
The generalizability of the findings is further impacted by the lack of nursing research 
related to the role of the healthcare provider in facilitating risk surveillance of 
occupational exposure to antineoplastic agents.
Sunmuuy
The oncogenic and teratogenic effects of antineoplastic agents are well 
established. However, the long term effects of continued exposure to small amounts of 
one or more of such drugs remain undetermined. For example, it is known that long-term 
use of potent immunosuppressive agents may result in the development of lymphoma. It 
is not known, however, at what drug level or over what period of time this may occur and 
how this correlates with possible drug levels achieved through occupational exposure 
during preparation and administration of hundreds or thousands of injectable and oral 
doses of these agents.
The danger to healthcare personnel firom handling hazardous drugs stems fi*om a 
combination of its inherent toxicity and the extent to which workers are exposed to the 
drug in the course of carrying out their duties. This exposure may be through inadvertent 
ingestion of the drug on foodstuffs (e.g., workers’ lunches), inhalation of drug dusts or 
droplets, or direct skin contact. Preventing Occupational Exposures to Antineoplastic and 
Other Hazardous Drugs in Healthcare Settings was recently published by NIOSH 
(DHHS Publication Number 2004-165). The purpose of this release was to increase 
awareness among healthcare workers and their employers about the health risks posed by
15
working with hazardous drugs and to provide them with measures to protect their 
health. To date, the research provides primary evidence that healthcare workers 
exposed to hazardous drugs during the course of their work are absorbing these drugs and 
are at risk for adverse outcomes.
Additional research in this area is needed, but awareness of the problem has led to 
overall reduction of e?q)osures, either by improved drug handling techniques or through 
the implementation of safety programs and thus fewer exposed healthcare workers are 
available for study. Definitive knowledge of the occupational dangers of handling 
hazardous drugs may someday be available through epidemiologic studies of healthcare 
workers.
In theory, correct and perfect preparation and handling techniques will prevent 
drug particles or droplets from escaping from their containers while they are being 
manipulated. Near-perfect technique is uncommon; therefore, contamination of the 
workplace is likely and worker exposure may increase without protective equipment and 
other safety measures. This is particularly true in the absence of any structured training 
and quality-assurance programs covering the proper handling of hazardous drugs.
CHAPTER n  
Review of Literature
This investigation is an integrative literature review which summarizes research 
on a topic of interest by placing the research problem in context and identifying gaps and 
weaknesses in prior studies to justify new investigations (Polit & Beck, 2004). For the 
purpose of this investigation, data-based and theory-based manuscripts were reviewed 
and critiqued using a knowledgebase template concerning occupational exposure to 
antineoplastic agents (see Appendix A). Literature reviewed totaled six data-based 
manuscripts and three theory-based manuscripts, which represented reviews of another 
one-hundred thirty references. In this chapter, an overview of the study variables is 
presented as it has emerged from the developing knowledgebase.
An Overview o f the Healthcare Literature Related to Risk Surveillance 
o f Occupational E rasu re to Antineoplastic Agents
According to a study by Brown (2000), that was indexed in MEDLINE, a number 
of pertinent conclusions were made concerning antineoplastic agents and occupational 
exposure. The data-based method was that of a descriptive design with a sample 
(#=126). A strength of the study was that the researchers employed genetic testing to 
validate chromosomal deviations resultant to occupational exposure to antineoplastic 
agent use among oncology nurses in a selected cancer clinic on the East coast. A 
weakness of the research was that generalizability of findings was limited due to the 
homogenous sample of convenience. The research does provide a foundation for fiirther 
study in this area; however, the convenience sampling used in the study may impact 
external validity. Results suggest that exposure to antineoplastic is a potential health
16
17
hazard. Findings suggest that exposure be kept to a minimum and the use protective 
measures are essential when handling antineoplastics.
In a study by Burgaz et al., 2002), that was conducted in Turkey and indexed in 
MEDLINE, conclusions concerning antineoplastic drugs, chromosomal aberrations, and 
nurse occupational exposure were reported. The data-based method was that of a 
descriptive design with a large sample (#=738). The study showed that increased genetic 
damage was directly a result of occupational exposure to antineoplastic agents. A 
weakness of the design was that only one antineoplastic agent, cyclophosphamide, was 
reviewed in relationship to occupational exposure. The study reveals a need to research 
the concept and domains with other antineoplastic agents. In addition, lengthy written 
questionnaires can be source of error as subjects tire of questions and completes survey 
too quickly. However, the large sample does provide a foundation for future research in 
this area. Of concern was the fact that a questionnaire was used to assess previous 
personnel exposure to cyclophosphamide. Accuracy of such data collection remains 
unclear, relying heavily on recollection. Analyses of CP in urine demonstrated compound 
absorption. Also, higher CP excretion rates were observed among nurses handling CP, 
suggesting a direct relation between handling CP and occupational exposure to CP. 
Increased frequency of structural CA in peripheral lymphocytes is associated with an 
increased overall risk for cancer. This warrants chromosomal changes to be regarded as 
potentially serious effects. Exposure to these genotoxic chemicals should be limited. This 
study also showed that increased genetic damage was evident in nurses at the population 
level due to occupational exposure to antineoplastics. Results suggest that exposure be 
kept to a minimum and protective measures are essential when handling antineoplastics.
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Also emphasized was the importance of the establishment and implementation of 
national regulations for handling these substances.
In a literature review by Gribben (2002), indexed in CINAHL, the concepts of 
antineoplastic agents, occupational exposure, and protective equipment were explored. 
The data-based manuscript followed the pattern of a systematic literature review. A 
strength of the study was that it examined factors influencing use of personal protective 
equipment and the development of acute adverse health effects. A weakness of the 
findings was that terms were not well-defined, which may obfuscate the author’s 
intended meaning. The systematic review provides the foundation for further research. 
The lack of clarity in literature selection may be a source of potential bias influencing the 
findings. This article examined the use of personal protective equipment and adverse 
health effects associated with antineoplastic use. Findings indicate that the use of gloves, 
mask, and goggles have a significant effect on reducing the likelihood of adverse health 
outcomes associated with antineoplastic use. In addition, diligent preparation of the drugs 
under a biological safety cabinet greatly reduces the potential for adverse health effects. 
Results suggest that exposure be kept to a minimum and protective measures are essential 
when handling antineoplastics. Also emphasized was the importance of the establishment 
and implementation of national regulations for handling these substances.
In a research study conducted by Larson and Khazeli (2003), indexed in 
MEDLINE, conclusion were reported regarding research of antineoplastics and air 
monitoring methods. The data-based method was that of a descriptive design. Strengths 
of the research is that it explored a variety of filter monitoring methods for 
antineoplastics. Data collection and analysis were done concurrently thereby reducing the
19
risk of miscoding or other analysis errors. A weakness of the study is that preparation 
of standards were obtained but could not always be verified by the analysis of blank or 
spiked samples. The conclusions of the study provide a foundation for further research in 
this area. A threat to the study was that the potential for cyclophosphamide to sublimate 
off filter material may account for potential skewed findings. This study addressed the 
issue of overall effectiveness of current monitoring media for antineoplastics. In addition, 
the study also looked at solid sorbent médias as a method of choice. Indications fi"om the 
study include the finding that filter methods are not acceptable for air monitoring of 
cyclophosphamide and possibly other antineoplastic agents. This information also 
supports the observation that the HEPA filter is not an acceptable control for biological 
safety cabinets that return filtered air to the work room.
In a study by Rodgers (2000), that was indexed in MEDLINE, variables 
concerning pharmacy personnel, antineoplastic agents, and occupational exposure were 
explored. The data-based method was that of a descriptive design in a considerable 
sample (N =348). A strength of the research was the extensive descriptive survey of 
personnel exposure to antineoplastics and use of personal protective equipment.
However, a weakness of the design was that lengthy, written questionnaires can be source 
of error as subjects tire of questions and completes survey too quickly. Moreover, nurses 
who fear their answer would exemplify them as ignorant or indifferent may not have 
answered truthfidly. The research provides a foundation for further study exploring these 
variables. A threat to the study was the potential for skewed findings since risk is 
subjective in nature. Moreover, the subject may not reveal true feelings to avoid being 
labeled as indifferent or uncaring which could alter the validity of the findings. This
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study looked at nurse perception of risk associated with antineoplastic use and 
examined the nurse’s demographics in relation to the use of personal; protective 
equipment. The study revealed that the use of personal protection was statistically 
significant in regards to the demographic variables which were defined for the study.
In a research study conducted by Sardas, Gok and Karakaya (2003), that was 
conducted in Turkey and indexed in MEDLINE, variables explored included: 
antineoplastic drugs, chromosome damage, and occupational exposure. The data-based 
method was that of a quasi-experimental design (n=23 nurses; n=50 control). A strength 
of the research was that this study examined a group of 23 oncology nurses working in 
different university hospitals in Turkey with a control group of 50 unexposed individuals. 
However, the lack of standardized microscope slide preparation could potentially skew 
test results. Even so, the research provides the foundation for future exploration of these 
variables. A threat to the study was that several slides did not demonstrate any 
relationship between occupational exposure to antineoplastics and increased sister 
chromatid exchanges. This article examines the increase in sister chromatid exchanges in 
circulating lymphocytes among nurses handling antineoplastic agents. This work has also 
shown that cigarette smoking causes a significant increase in SCE’s. Overall, this study 
supports the existence of an association between professional exposure to antineoplastic 
drugs and an increase in SCE’s in lymphocytes and that smoking contributes to elevated 
SCE rates.
In a study by Thompson (2004), that was indexed in MEDLINE, the variables of 
hazardous chemicals, antineoplastic agents, and occupational exposure were explored.
The data-based method was that of a descriptive design in a large sample (#=421). A
21
strength of the study was that the authors stressed the fact that antineoplastic use is 
appropriate and beneficial to patients experiencing a terminal disease such as cancer. 
However, there is significant risk for adverse health effects from occupational exposure.
A weakness of the design was that the sample size was limited to members of Oncology 
Nursing Society. This study validated previous research that workplace exposure to 
antineoplastics is potential health risk. Adverse outcomes are associated highly with the 
extent of exposure as well as the toxicity of the drugs. However, the homogenous sample 
of convenience limits the ability to generalize the findings to other nurses without 
membership in ONS. This study looked at personnel exposure to antineoplastic agents in 
the workplace. Findings indicate the potential exists for adverse health effects with the 
use of these drugs. Further research should involve the deliberate sampling of diverse 
populations as well as the use of personal protective equipment to decrease the chances of 
risk.
In a research study conducted by Valanis, Vollmer, Labuhn, and Glass (2001), 
that was indexed in MEDLINE, the variables of antineoplastic agents, absorption, and 
toxicity were explored. The data-based method used was that of a descriptive design in a 
large sample (#=800), A strength of the study was that the setting included large medical 
centers where data was easily accessible. A weakness of the study was the lack of clarity 
in method may mask internal threats to validity and reliability of findings. Results of the 
study provide foundation for friture research regarding acute adverse effects. A threat to 
the study was the volunteer-based sample and moderate participation rates are clear 
limitations-sample essentially protected group. This study looked at the relationship 
between occupational exposure to antineoplastic drugs and the presence of acute
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symptoms of exposure. Handling of these drugs was associated with a significant 
increase in the number of symptoms compared with controls. Skin contact was the most 
predominant predictor of symptoms. The number of doses and extent of protection were 
significantly associated with the number of symptoms as well.
Summary
In reviewing the literature, it was determined that a consensus among the 
researchers exists regarding the feet that the drugs are cytotoxic and have the potential for 
causing adverse health effects, both short-term and long-term. Research supported the 
notion that three variables have emerged as being best predictors of adverse effects.
These variables include: duration of exposure, toxicity of the drug, and use of personal 
protective gear. An fwea of disagreement among the researchers was found regarding the 
degree to which personal protective equipment was found to be effective. Moreover, 
current research regarding antineoplastic monitoring methods was found to be less 
effective than originally expected. An interesting finding of the literature review was the 
notion that complacency in working with such drugs, can kill. For healthcare providers, 
the importance of screening for occupational exposure is critical. Moreover, in 
occupational health environments, the importance of a pre-employment screening and 
regular screenings thereafter is essential.
CHAPTER m  
Design and Methodology
This chapter will present the parameters used for this research investigation. The 
approach that was used was that of an evidence-based systematic review. According to 
Sackett, Straus, Richardson, Rosenberg, and Haynes (2000) evidence-based practice 
attempts to integrate best research evidence with clinical expertise and patient values.
The literature selection procedure and literature analysis procedure is detailed in this 
chapter.
Approach
An integrated literature review, which is a review of research that amasses 
comprehensive information on a topic, weighs pieces of evidence, and integrates 
information to draw conclusions about the state of knowledge, will be used for this study. 
This investigation is an evidence-based practice systematic review. While an integrative 
literature review summarizes research on a topic of interest, by placing the research 
problem in context and identifying gaps and weaknesses in prior studies to justify the 
new investigation (Polit & Beck, 2004), evidence-based practice seeks to integrate best 
research evidence with clinical expertise and patient values (Sackett, Straus, Richardson, 
Rosenberg, & Haynes, 2000). A summary of the current literature regarding the role of 
the healthcare provider in facilitating risk surveillance of occupational exposure to 
antineoplastic agents is provided.
Literature Selection Procedure
A systematic search of CINAHL, MEDLINE, and the Cochrane Library was 
conducted for the relevant literature concerning the role of the healthcare provider in
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facilitating risk surveillance of occupational exposure to antineoplastic agents. The 
reference list accompanying each article was then manually reviewed for fiirther articles 
pertaining to the subject. Articles were selected based on inclusion of at least one of the 
relevant concepts, whether as the focus of the article or as part of a broader topic. Other 
informative articles were also included to fiirther explore the knowledgebase.
The systematic review of the literature began with CINAHL to find relevant 
nursing literature on the role of the healthcare provider in facilitating risk surveillance of 
occupational exposure to antineoplastic agents. Next, MEDLINE and then the Cochrane 
Library were evaluated for further relevant literature. Journal articles were obtained 
through the Mississippi University for Women library, via Internet databases and 
interlibrary loan. The review incorporated data beyond nursing literature to expand the 
knowledgebase for a thorough review, thus providing a multi-disciplinary approach.
References utilized were relevant and applicable to this investigation. The 
references were obtained from reputable and respected scholarly journals in the 
healthcare fields. The evidence-based practice procedure (Sackett, et al., 2000) for the 
systematic review comprises the following steps:
1. convert the need for information (about prevention, diagnosis, prognosis, 
therapy, causation, etc.) into research questions.
2. track down the best evidence with which to answer the questions using a 
variety of database strategies.
3. critically appraise the evidence for its validity (closeness to the truth), impact 
(size of the effect), and applicability (usefulness in our clinical practice 
addressing both sensitivity and specificity).
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4. integrate the critical appraisal with clinical expertise and the patient’s 
unique biology, values and circumstances (p. 3-4).
Literature Analysis Procedure
For the purpose of this study, a knowledgebase of literature critiques will be used 
to organize the literature by source and date, variables of interest, literature type and 
research tools, research design and sample size, theoretical foundation, references, and 
key findings. Data (provided in Appendix A) is analyzed in terms of relevancy of 
findings and then summarized utilizing a chart format to assist in application of findings 
to the clinical problem. The findings document the current state of knowledge available 
that is discussed in Chapter Four according to the research questions regarding the role of 
the healthcare provider in facilitating risk surveillance of occupational exposure to 
antineoplastic agents.
Sununary
This chapter detailed the parameters for this research investigation. This 
evidence-based practice systematic review of the literature will be conducted utilizing the 
literature selection procedure and literature analysis procedure highlighted above.
Through this process, the research questions regarding the role of the healthcare provider 
in facilitating risk surveillance of occupational exposure to antineoplastic agents, 
will be answered.
CHAPTER IV 
Knowledgebase Findings and Practice-Based Application
The purpose of this section is to expound the findings of the knowledgebase 
derived fi*om this evidenced-based systemic literature review. Tables showing pertinent 
findings fi*om of this knowledgebase are provided with practice-based applications fi-om 
current clinical practice guidelines.
Knowledgebase Findings 
In order to obtain the knowledgebase findings, a systematic literature search of 
CINAHL, MEDLINE, and the Cochrane Library was conducted by this author. The 
literature reviewed totaled 8 citations, which represented another 122 references.
Findings fi*om the literature reviewed are addressed in this section in terms of each 
research question generated for the scope of this study.
Research Question One
Research question one asks: What is the level of healthcare knowledge regarding 
the role of the healthcare provider in facilitating risk surveillance of occupational 
exposure to antineoplastic agents? The results of this literature review reflect the growing 
knowledge of the risks associated with exposure to antineoplastic drugs, as well as the 
development and application of policies aimed at preventing occupational exposure of 
nurses to these drugs. Healthcare professionals think of antineoplastic drugs in terms of 
their therapeutic value to cancer patients. However, there’s a risk of serious health 




Characteristics o f Citations Reviewed
Citation Type Database
Brown, 2000 Data-based (descriptive) MEDLINE
Burgaz et al., 2002 Data-based (descriptive) MEDLINE
Gribben, 2002 Data-based (systematic CINAHL
literature review)
Larson & Khazeli, 2003 Data-based (descriptive) MEDLINE
Rodgers, 2000 Data-based (descriptive) MEDLINE
Sardas, Gok & Karakaya, 2003 Data-based (quasi- MEDLINE
experimental)
Thompson, 2004 Data-based (descriptive) MEDLINE
Valanis, Vollmer, Labuhn, & Glass, Data-based (descriptive) MEDLINE
2001
Note, Total number of citations reviewed = 8.
Research Question Two
Research question two asks; According to the literature, how can healthcare 
providers contribute to cost-effective, high-quality care by facilitating risk surveillance of 
occupational hazards? Studies have demonstrated widespread environmental 
contamination by hazardous drugs in preparation and administration areas, as well as 
human uptake. Healthcare providers can facilitate the delivery of high-quality healthcare 
to oncology patients by complying with current standards and recommendations set forth 
by agencies such as OSHA, Research suggests the use of personal protective equipment
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and diligent drug preparation reduce the likelihood of an occupational hazard. 
Nonetheless, workplace exposures should be immediately reported, the events 
meticulously documented, and any injuries treated without delay.
Research Question Three
Research question three asks: According to the literature, how can healthcare 
providers contribute to cost-effective, high-quality care by facilitating risk surveillance of 
exposure to antineoplastic agents? Hazardous drugs are drugs that pose a potential health 
risk to healthcare workers who may be exposed during preparation or administration.
Such drugs require special handling because of their inherent toxicities. The health and 
safety of workers who handle hazardous drugs should be a high priority. Medical 
monitoring and risk surveillance programs enhance the safety and overall wellbeing of 
the healthcare providers.
Practice-Based Application 
In order to obtain the practice-based findings, a search for clinical practice 
guidelines housed in the world wide web (WWW) was conducted by this author. The 
web revealed a number of sites with clinical practice guideline holdings including the 
Centers for Disease Control and the Agency for Healthcare Research and Quality.
Clinical practice guideline findings fi*om the web holdings are addressed in this section in 
terms of each research question generated for the scope of this study.
Research Question One
Research question one asks: What is the level of healthcare knowledge regarding 
the role of the healthcare provider in facilitating risk surveillance of occupational 
exposure to antineoplastic agents? The clinical practice guidelines concerning
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occupational exposure to antineoplastic agents according to NIOSH (CDC, 2004), 
acknowledges some important practices. The carcinogenicity of several antineoplastic 
drugs has been well established. A number o f studies indicate that antineoplastic drugs 
may cause increased genotoxic effects in pharmacists and nurses exposed in the 
workplace (Falck et al., 1979; Valanis, Vollmer, Labuhn, & Glass, 2001). Several studies 
that have not linked genotoxic effects with worker exposures may be explained by 
technical confounders and a lack of accurate blood and urine sampling in exposed 
workers. The weight of evidence associates hazardous drug exposures at work with 
increased genotoxicity. Curr^tly no recommended exposure limits have been 
established. Recommended guidelines and standards have been created to keep exposure 
and risk at a minimum.
Table 3
Sumnuay o f Ciinical Practice Guidelines Reviewed
Source of Guidelines Website URL
Agency for Healthcare Research and Quality www.ahra.sov
Centers for Disease Control and Prevention www.cdc.2ov/niosh/docs/2004-165/
Occupational Safety and Health Administration www.osha.20v
Oncology Nursing Society www.ons.ors
Note, Total number of guidelines reviewed = 3.
Research Question Two
Research question two asks. According to the literature, how can healthcare 
providers contribute to cost-effective, high-quality care by facilitating risk surveillance of 
occupational hazards? High-quality, cost-effective care for the oncology patient is
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important. Employee medical surveillance is an additional strategy for optimizing the 
health status of persons who work in settings where hazards exist. Medical risk 
surveillance involves a carefiil search for unexpected outcomes that might herald new or 
uncontrolled hazards in the workplace. It most often refers to the systematic collection, 
analysis and dissemination of health information on groups of workers. For risk 
surveillance to be an effective warning mechanism, it must be connected to preventive 
safety and health actions. Healthcare providers overseeing the surveillance effort must 
take the lead in ensuring that quality issues relating to medical screening and surveillance 
are adequately addressed. This step is important because when otherwise healthy persons 
are screened, end points of significance are usually more subtle than they are in overtly 
symptomatic persons. Adhering to available guidelines also facilitates epidemiologic 
review because of the quality and integrity of the data obtained.
Research Question Three
Research question three asks: According to the literature, how can healthcare 
providers contribute to cost-effective, high-quality care by facilitating risk surveillance of 
exposure to antineoplastic agents? Occupational exposure to anticancer drugs has been 
shown to be associated with both increased incidence of malignancy in male and female 
healthcare workers, as well as fetal developmental effects in their offspring (Valanis et 
al., 2001). It is therefore essential for oncology nurses to be aware of the potential effects 
of cytotoxic agents, and diligent in taking the steps needed to minimize exposure. Several 
studies have documented the surface contamination that can occur throughout the 
healthcare setting. Examination of work practices is important to reduce exposure. Data 
indicate that exposure is lower than in the past, but also that cleaning techniques remain
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inefficient, that ineffective surface cleaning can result in spreading contamination, and 
that surface contamination can and does result in worker contamination.
Summary
The purpose of this investigation was to explore the literature regarding the 
current level of healthcare knowledge regarding the role of the healthcare provider in 
facilitating risk surveillance of occupational exposure to antineoplastic agents. The 
results of this investigation suggest that occupational exposure to cytotoxic substances 
continues to be a hazard in the healthcare setting; however, the literature did not provide 
consistent significant findings to prove a relationship between occupational exposure and 
mutagenesis. The three major variables in determining severity of exposure include 
duration of exposure, toxicity of the drug, and the use of personal protective equipment.
It is essential for oncology nurses to understand the risk of hazardous drug exposure in all 
areas of the healthcare setting, and to ensure careful and proper work practices—such as 
using appropriate BSC techniques, changing gloves fi^equently, swabbing final products, 
and using appropriate drug cleaning and inactivation agents—to reduce the risk of 
exposure for themselves and their colleagues.
CHAPTER V 
Evidence-Based Conclusions, Implications, and Recommendations
The potential adverse health risks from occupational exposure to hazardous drugs 
are based on the inherent toxicities of the drugs. The same health effects that occur in 
patients who receive therapeutic doses of the drugs are possible if employees are 
exposed. Hazardous drugs are genotoxic, carcinogenic, teratogenic or cause 
developmental toxicity. Many result in adverse reproductive outcomes and cause organ 
toxicity at low doses.
Evidence for continued risk of occupational exposure to antineoplastic agents is 
abundant; however, nurses' use of the recommended precautions is not universal. This 
may be related to a lack of information or to a lack of serious concern for the potential 
hazards, there was little interest or concern among health care workers. Information about 
health effects from low levels of occupational exposure is sparse in recent literature.
Many reports of adverse effects were published before the implementation of safe 
handling precautions. This has contributed to the lack of concern among nurses regarding 
hazardous drug handling. Hazardous drug handling is potentially risky work. Many 
nurses have the potential to be exposed to hazardous drugs in the workplace.
OSHA, ASHP, ONS, and NIOSH all provide guidelines for the safe handling of 
hazardous drugs. While not providing complete protection, it is believed that adherence 
to current recommendations will reduce health care workers’ exposure. By reducing 
exposure, the negative health effects should be reduced. It is time for nurses to take their 
own occupational safety as seriously as the safety of the patients under their care.
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Summary o f the Investigation
This literature review was undertaken with the focus of exploring the available 
literature regarding the current level of healthcare knowledge regarding the role o f the 
healthcare provider in fecilitating risk surveillance of occupational exposure to 
antineoplastic agents. A review of the literature revealed the need to fiirther the level of 
knowledge regarding this issue. This chapter provides a summary of the literature review, 
including interpretation of the findings and the conclusions drawn fi-om the findings, as 
well as limitations of the study and recommendations for further research.
Interpretation o f Findings with Conclusions 
According to the literature analysis, the findings fi*om this investigation 
demonstrate a consensus in the literature regarding the current level o f healthcare 
knowledge regarding the role of the healthcare provider in facilitating risk surveillance of 
occupational exposure to antineoplastic agents. An examination of the literature revealed 
that this area requires further investigation. Conclusions drawn fi-om the findings reveal 
that healthcare providers are often well aware of the drug’s potential toxicity; however 
they disregard recommended national guidelines set forth. In tins section, the 
interpretation of the findings will be presented in response to each research question. 
Research Question One
The first research question asked, “What is the level of healthcare knowledge 
regarding the role of the healthcare provider in facilitating risk surveillance of 
occupational exposure to antineoplastic agents?” The results of the research indicate the 
level of healthcare knowledge regarding the role of the healthcare provider in facilitating 
risk surveillance of occupational exposure to antineoplastic agents is limited. Much has
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been written about securing caregivers' compliance with practice guidelines and other 
best practice recommendations. However, it appears that defining ideal practices may be 
easier than getting clinicians to change their long-established habits. Caregivers seem to 
resist change even when it's the right thing to do. For example, in a study of how well 
oncology nurses comply with OSHA guidelines for handling cytotoxic drugs, researchers 
found that some of the nurses used some protective equipment when preparing and 
administering cytotoxic drugs, but the type of equipment and its fi*equency of use did not 
specifically meet OSHA guidelines (Gribben, 2002).
Research Question Two
The second research question asked, “According to the literature, how can 
healthcare providers contribute to cost-effective, high-quality care by facilitating risk 
surveillance of occupational hazards?” The results of the research indicate that cost- 
effective, high-quality care is enhanced by facilitating risk surveillance of occupational 
hazards. Moreover, facilitating risk surveillance of occupational hazards was addressed in 
the knowledgebase in that authors agreed that risk surveillance was important, but not 
necessarily conducted fi*om the perspective of occupational hazard exposure.
Conversely, facilitating risk surveillance of occupational hazards was addressed in the 
clinical guidelines reviewed in that guidelines posted by various agencies stressed the 
importance and method, but differed dramatically in content and process. The consensus 
was that healthcare providers should implement surveillance efforts and take the lead in 
ensuring that quality issues relating to risk surveillance are adequately addressed.
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Research Question Three
Research question three asks: According to the literature, how can healthcare 
providers contribute to cost-effective, high-quality care by facilitating risk surveillance of 
exposure to antineoplastic agents? The results of the research indicate that cost-effective, 
high-quality care is enhanced by facilitating risk surveillance of exposure to 
antineoplastic agents. Moreover, facilitating risk surveillance of exposure to 
antineoplastic agents was addressed in the knowledgebase in that authors agreed that risk 
surveillance was important, but not necessarily conducted from the perspective of 
antineoplastic agent exposure. Conversely, facilitating risk surveillance of exposure to 
antineoplastic agents was addressed in the clinical guidelines reviewed in that guidelines 
posted by various agencies stressed the importance and method, but differed dramatically 
in content and process. The consensus was that healthcare providers should implement 
surveillance efforts and take the lead in ensuring that quality issues relating to risk 
surveillance are adequately addressed.
Limitations
There were limitations identified in this study. Some information obtained cannot 
be generalized beyond the scope of the research that was reviewed. Also, lengthy written 
questionnaires can be source of error as subjects’ tire of questions and completes survey 
too quickly. Most of the research was limited to specific populations and locations, 




The review of the literature revealed limited documentation regarding the level of 
healthcare knowledge regarding the role of the healthcare provider in facilitating risk 
surveillance of occupational exposure to antineoplastic agents. There was agreement that 
duration of exposure, toxicity of drug, and use of personal protective equipment directly 
affect exposure risk. Gribben (2002) showed that use and availability of personal 
protective equipment when handling chemotherapy have increased, but medical 
monitoring of exposed employees still is neither widely practiced nor consistent with 
OSHA guidelines.
Safety concerns and potential adverse health effects associated with the 
occupational handling of chemotherapeutic agents have been reported. Historically, 
nurses' adherence to chemotherapy-handling guidelines has been poor. Results suggest 
that adherence is increasing. The investigation of the literature has resulted in 
implications and recommendations focused on nursing theory, nursing research, 
advanced nursing practice, nurse practitioner education, and health policy. Each o f these 
areas will be considered in this section.
Nursing Theory
The theoretical foundation for this study was Becker’s Protection Motivation 
Theory. Although primarily not a nursing theory, it has been used in many studies that 
attempt to explain why behavioral choices are made, thus is an appropriate theoretical 
framework for this study.
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Nursing Research
The level of healthcare knowledge regarding risk surveillance of occupational 
exposure to antineoplastic agents is very scant. Safety concerns and potential adverse 
health effects associated with the occupational handling of chemotherapeutic agents have 
been reported. Historically, nurses' adherence to chemotherapy-handling guidelines has 
been poor. Results suggest that adherence is increasing; however, research is lacking 
regarding nurses' level of knowledge of and specific barriers to safe handling of 
chemotherapy. Although adherence to recommended guidelines is increasing, further 
research regarding specific barriers to safe handling of chemotherapy is needed.
Research empowers practice and enhances the status of nursing as a profession by 
expanding nursing’s scientific knowledgebase. Research findings not only improve 
patient care but also affect the healthcare system (Polit & Beck, 2004).
Advanced Nursing Practice
Oncology nurses are key professionals in the delivery of skilled care to people 
with cancer. These nurses are challenged with the responsibility of coordinating quality 
patient care and administering chemotherapy. The administration of chemotherapeutic 
agents is an integral part of nurses’ role in the provision of care. Cytostatic drugs possess 
toxic properties and may cause mutagenic, carcinogenic and teratogenic effects.
Therefore, nurses handling these drugs in the course of their profession may face serious 
health risks. The occupational exposure risk of cytotoxic agents was first documented in 
health care personnel by Falck et al. (1979) who reported an elevated frequency of 
mutagenesis in spot urines after continuous low-level exposure within a group of
38
oncology nurses. Proper handling of these drugs combined with the use of personal 
protective equipment can drastically reduce this threat.
Nurse PractiHoner Education
In nursing, there is an emphasis on providing competent, safe nursing care to 
enhance patient safety. However, intertwined in the promotion of safe patient care is the 
critical issue of nurse safety. Nurse Practitioners are renowned for their superb 
communication and educating ability. As a result, they should promote healthcare 
provider safety in relation to antineoplastic handling as well.
Health Policy
As a result of the recent trend toward managed care, it has become essential for 
healthcare providers to consider cost-effective, high-quality strategies in providing care 
for oncology patients. The oncology Nurse Practitioner must assume a leadership role in 
promoting risk surveillance programs through education, legislation, and social policy 
change.
Summary
According to Martin and Larson (2003), healthcare professionals involved with 
handling antineoplastic drugs may be exposed inadvertently to these agents, placing them 
at potential risk for acute and long-term adverse effects. For example, cyclophosphamide 
one of the most frequently used antineoplastic agents in clinical treatment facilities, is a 
known human carcinogen (Larson, Khazaeli, & Dillon, 2003). While the health risks 
associated with cytotoxic use have been well established, there is little information 
available about how people perceive these risks, particularly among those most affected 
by it-chemotherapy nurses. Therefore, the purpose of this Evidence Based Practice (EBP)
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project was to develop a nurse practitioner knowledgebase regarding the impact o f risk 
perception on the cytotoxic agent safety behaviors of oncology nurses. The research 
questions asked: (a) what is the level of healthcare knowledge regarding the role of the 
healthcare provider in facilitating risk surveillance of occupational exposure to 
antineoplastic agents? (b) according to the literature, how can healthcare providers 
contribute to cost-effective, high-quality care by facilitating risk surveillance of 
occupational hazards? and (c) according to the literature, how can healthcare providers 
contribute to cost-effective, high-quality care by facilitating risk surveillance of exposure 
to antmeoplastic agents? A Boolean computer search of nursing and medical literature 
for theory-based, data-based, randomized controlled trials for citations utilizing 
CINAHL, MEDLINE, and the Cochrane Library was conducted for this systematic 
review.
Becker’s Health Belief Model (1974) served as the theoretical foundation for this 
clinical project and guided the systematic review through data collection of the healthcare 
literature. Literature reviewed totaled 21 manuscripts, which represented reviews of 
another 419 references. Studies of healthcare workers have shown that occupational 
exposure to antineoplastic agents has caused acute adverse effects such as nausea, 
headache and dizziness (Valanis, Vollmer, Labuhn, and Glass, 1997). Exposure risk and 
its relationship to healthcare professionals’ compliance to established protocols for the 
safe handling and administration of chemotherapy agents continues to be a concern for 
health care institutions (Ritchie, McAdams, and Fritz, 2000). The literature reviewed for 
this study recommends compliance with established safety guidelines to ensure adequate 
protection to those involved in the handling, administration, and care of patients receiving
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antineoplastic agents. Yet despite the adoption of these guidelines in healthcare 
institutions, the current literature also suggests that many workers do not follow the 
standards established by their employers and current OSHA guidelines, putting 
themselves at risk for exposure to potential mutagenicity, alterations in fertility and long­
term effects from chemotherapy agents (Valanis, Vollmer, Labuhn, and Glass, 1997).
Using an Evidence Based Medicine (EBM) approach, based on that of Sackett, 
Straus, Richardson, Rosenberg, and Haynes (2000), a knowledgebase was developed 
according to methods described by Davidson (2003) in which key findings from the 
systematic review of randomized control trials, data-based and theory-based literature 
were compared with current practice guidelines, resulting in a number of safe practice 
recommendations. These recommendations emphasize that safe levels of exposure to 
antineoplastic agents have not been determined therefore; it is essential to minimize 
exposure.
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